913 related articles for article (PubMed ID: 23001123)
1. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
[TBL] [Abstract][Full Text] [Related]
2. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
3. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
5. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
6. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
7. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.
Karki A; Campbell KB; Mozumder S; Fisher AJ; Beal PA
Biochemistry; 2024 Feb; 63(3):282-293. PubMed ID: 38190734
[TBL] [Abstract][Full Text] [Related]
8. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
9. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures.
Fisher AJ; Beal PA
RNA Biol; 2017 Feb; 14(2):164-170. PubMed ID: 27937139
[TBL] [Abstract][Full Text] [Related]
10. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
12. Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama T; Kawahara Y
Cell Mol Life Sci; 2020 Aug; 77(15):2931-2948. PubMed ID: 31996954
[TBL] [Abstract][Full Text] [Related]
13. Z-DNA and Z-RNA in human disease.
Herbert A
Commun Biol; 2019; 2():7. PubMed ID: 30729177
[TBL] [Abstract][Full Text] [Related]
14. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
15. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
Orecchini E; Frassinelli L; Michienzi A
RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
[TBL] [Abstract][Full Text] [Related]
16. RNA Editing in Interferonopathies.
Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
Methods Mol Biol; 2021; 2181():269-286. PubMed ID: 32729086
[TBL] [Abstract][Full Text] [Related]
17. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
George CX; Ramaswami G; Li JB; Samuel CE
J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
[TBL] [Abstract][Full Text] [Related]
18. Bilateral striatal necrosis in two subjects with Aicardi-Goutières syndrome due to mutations in ADAR1 (AGS6).
La Piana R; Uggetti C; Olivieri I; Tonduti D; Balottin U; Fazzi E; Orcesi S
Am J Med Genet A; 2014 Mar; 164A(3):815-9. PubMed ID: 24376015
[TBL] [Abstract][Full Text] [Related]
19. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
20. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
